542 / 1835
The benefit of rituximab is maintained over time
Coiffier B et al. Blood 2010;116:2040-2045
1.00
0.75
0.50
0.25
0.00
Overall survival
Time (years)
0
2
4
6
8
10
12
Arm A: CHOP
Arm B: CHOP + Rituximab
GELA LNH-98.5 10-year follow-up